Northern Lights Fund Trust III Delays ETF Registration Amendment
Northern Lights Fund Trust III has filed to delay the effectiveness of its ETF registration amendment, impacting the investment landscape.
Barclays Bank unveils new Performance Leveraged Upside Securities
Barclays Bank PLC announces a new offering of Performance Leveraged Upside Securities linked to the Russell 2000 Index, emphasizing risk and equity returns.
Radcliffe Domestic Multi-Strategy Fund amends private offering
Radcliffe Domestic Multi-Strategy Fund, L.P. updates its private offering details in a recent SEC filing, reflecting changes in its investment strategy.
Morgan Stanley Finance files pricing supplement for new securities
Morgan Stanley Finance LLC files a pricing supplement for Performance Leveraged Upside Securities, focusing on Nasdaq-100 and S&P 500 indices.
Wells Fargo Finance files pricing supplement for notes
Wells Fargo Finance LLC has filed a pricing supplement for Medium-Term Notes, reflecting ongoing innovation in the national commercial banking sector.
AuguStar Variable Account A Announces Portfolio Reorganizations
AuguStar Variable Account A has approved three reorganizations for its variable annuity and life insurance portfolios to enhance efficiency.
Morgan Stanley Finance LLC Files Pricing Supplement for New Securities
Morgan Stanley Finance LLC has filed a pricing supplement for new structured investments, reflecting a trend in the securities industry towards innovative financial products.
Barclays Bank announces new $292,000 note offering
Barclays Bank PLC has filed a pricing supplement for $292,000 in autocallable leveraged barrier notes, expanding its offerings in the commercial banking sector.
General Motors Financial files issuer free writing prospectus
General Motors Financial Company, Inc. files an issuer free writing prospectus to supplement its existing capital-raising efforts, impacting the finance services industry.
GAM Holding AG Reports $1.2 Billion in Investment Holdings
GAM Holding AG reveals over $1.2 billion in investment holdings in its latest filing, showcasing strategic positioning in the investment management sector.
Tactical Tilt Overlay LLC Amends Private Offering Details
Tactical Tilt Overlay LLC has amended its private offering, reflecting ongoing adjustments in its investment strategy and compliance with SEC regulations.
Radcliffe Domestic Ultra Short Duration Fund Amends Offering
Radcliffe Domestic Ultra Short Duration Fund amends its offering, signaling changes in investment strategy and compliance in the hedge fund sector.
E.D.E.N.Nexus LLC files to raise $12 million through SAFEs
E.D.E.N.Nexus LLC has filed to raise $12 million via SAFEs, indicating growth ambitions with $2.66 million already sold. Minimum investment set at $250,000.
Morgan Stanley Finance files pricing supplement for new securities
Morgan Stanley Finance LLC has filed a pricing supplement for Enhanced Trigger Jump Securities maturing in December 2027, expanding its structured investment offerings.
Morgan Stanley Finance LLC Files Pricing Supplement for Securities
Morgan Stanley Finance LLC files a pricing supplement for structured investments, enhancing its offerings in the securities market.
AuguStar Variable Account A Announces Portfolio Reorganizations
AuguStar Variable Account A has approved reorganizations for its variable annuity and life insurance portfolios, aiming for better efficiency and cost management.
Principal Funds Updates Prospectus with New Portfolio Managers
Principal Funds, Inc. announces new portfolio managers in its updated prospectus, signaling a strategic shift in management for its investment funds.
Abdalla Filho Jose Joao Reports Major Share Transactions
Abdalla Filho Jose Joao disclosed significant transactions involving AXIA Energia S.A. shares, reflecting strategic shifts in ownership.
Duarte Ira Reports Significant Stock Transactions at Heron
Duarte Ira, CFO of Heron Therapeutics, reports multiple stock transactions, indicating strong confidence in the company's future amidst industry scrutiny.
Utah Medical Products Inc. Raises Quarterly Cash Dividend
Utah Medical Products Inc. increases its quarterly cash dividend to $0.315 per share, reflecting a 1.6% rise, effective January 5, 2027.